On February 4, 2016, Noubar Afeyan, Ph.D. notified BG Medicine, Inc. that he was resigning from the Company's Board of Directors, effective as of that date. On February 4, 2016, the Board appointed Jeffrey R. Luber, JD, MBA, to join the Board to serve as a Class I director until the 2018 Annual Meeting of Stockholders and until his successor has been duly elected and qualified, or until his earlier resignation, retirement, removal or death. The Board also appointed Mr. Luber to the Audit Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2016 | BG Medicine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2015 | CI |
2016 | BG Medicine Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 11 | |
-19.01% | 56.28M |
- Stock Market
- Equities
- BGMD Stock
- News BG Medicine, Inc.
- BG Medicine Announces Board Changes